Retension Pharmaceuticals Statistics

NASDAQ: RTSNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.32+0.79 (+7.50%)

At close: Oct 12, 4:00 PM ET · Delayed 15 min

After hours: 11.30 -0.18%

Retension Pharmaceuticals by the numbers

Retension Pharmaceuticals has a market capitalization of $89.2 million based on 7.88M shares outstanding. With trailing EPS of $-2.61, Retension Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.5% above its 50-day average and 7.5% above its 200-day average.

Average daily trading volume is 789.20K shares, or about $8.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RTSN valuation vs. peer median

RTSN compared with the median of 8 peer companies
Metric	RTSN	Peer median	Difference
Market cap	$89.22M	$86.26M	+3%
Avg. volume	789.20K	123.67K	+538%

Peer median across 8 companies: RLYB, QUCY, CTOR, PMN, EQ, ACRV, AARD, TELO.

Valuation

Market cap: $89.22M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-2.61
Shares outstanding: 7.88M

Price and trading

Previous close: 10.53
Open: 10.88
Day range: 10.16 – 11.79
52-week range: 9.66 – 11.79
50-day moving average: 10.53
200-day moving average: 10.53
Beta: —
Volume: 173.68K
Average volume: 789.20K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 89.22M
Eps: -2.61
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 11.79
Week52 Low: 9.66
Avg Volume: 789.20K
Shares Outstanding: 7.88M
Ma50: 10.53
Ma200: 10.53
Pct From52w High: -3.99%
Pct From52w Low: 17.18%